Skip to main content
. 2019 Jun 6;12:255–262. doi: 10.2147/CEG.S207333

Figure 2.

Figure 2

(A) Kaplan-Meier curve for disease-free survival (DFS) for patients with distal cholangiocarcinoma according to DFS in lymphatic invasion; DFS rates in the lymphatic invasion (0) group were significantly better than those in the lymphatic invasion (1, 2, 3) group (P<0.001). (B) Kaplan-Meier curve for overall survival (OS) for patients with distal cholangiocarcinoma according to lymphatic invasion; OS rates in the lymphatic invasion (0) group were significantly better than those in the lymphatic invasion (1, 2, 3) group (P<0.001).